CURE Pharmaceutical
Making Medicine Melt in Your Mouth
Problem
Challenge
CURE retained OWC to educate the market on its innovative drug delivery platform, a thin film much like a Listerine breath strip, so patients don’t have to swallow pills, increasing the absorption in the body and reducing toxicity. OWC was to raise CURE’s profile among pharmaceutical companies, investors and potential partners. OWC developed a campaign to create awareness for CURE’s proprietary delivery technologies, pioneering research and partnerships in the sector. OWC secured coverage in key pharma, biotech, healthcare and financial trades, as well as key business outlets. The success resulting from OWC’s campaigns created new business opportunities, attracted the attention from potential partners and solidified its relationship with investors and advisors.
What We Did
Implementation
The Impact
Quantitative Results
The Impact
Qualitative Results
CURE Pharmaceutical has become the go-to partner for pharmaceutical drug delivery tech in the cannabis industry, even being included for the first time in the global oral thin film drugs market analyst report by Market Research Future (MRFR) along the industry heavy-weights Pfizer Inc., Johnson & Johnson Services, Inc., Novartis AG and GlaxoSmithKline Plc.
In-depth features of CURE’s buccal oral thin film technology ran in key trade publications such as Drug Development and Delivery and PharmaVOICE, which are two key outlets for CURE.
- Top-tier financial and business outlets included CURE as part of their coverage of the pharma, oral thin film and cannabis spaces, including Motley Fool, The Wall Street Transcript, Seeking Alpha, The Rose Sheet and Proactive Investors.
Coverage in local publications such as San Fernando Valley Business Journal and The VC Star (part of the USA Today network) raised CURE’s local profile in an Amgen dominated area, attracting new talent in the form of three new executive hires and three Board of Director additions this year.
As a direct result of OWC’s campaign, new business opportunities and partnerships have developed with top cannabis companies for medical development.